Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

AML watch: The Egmont Group steps up enforcement against terrorist financing

The Egmont Group — Financial Intelligence Units from 151 jurisdictions, with 19 other observer organizations — issued its latest Communiqué from its meeting in Monaco last week, targeting terrorist financing.

The Egmont Group, founded in 1995, is used by enforcement agencies to share information and help each other develop evidence to prosecute financial crimes, such as money laundering, tax evasion, and graft.… Continue Reading

Russia demands Transparency International register as a ‘foreign agent’

Prosecutors in Moscow warned the Russian branch of Transparency International to register as a foreign agent, TI-Russia said in a statement posted on its website Friday.

Prosecutors told the anti-corruption NGO that its “actual activity includes interfering with the government’s policy in the fight against corruption by lobbying its own proposals to change it,” TI’s statement said.… Continue Reading

Novartis employee pleads guilty in Poland bribe case

An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.

Poland’s anti-corruption bureau charged two women with bribery. Prosecutors said they gave a health fund official a tourist trip worth more than $1,000 in exchange for backing the sale of a particular drug, Reuters said.… Continue Reading

GSK confirms Jordan, Lebanon bribe probes

GlaxoSmithKline said it is investigating allegations of bribery in Jordan and Lebanon first reported by the media.

The UK-based pharma giant said in a statement Wednesday the probes are ongoing.

GSK said it has a “zero tolerance” for illegal behavior.… Continue Reading